KLK3 and anemia (phenotype): The serum PSA level at the start of chemotherapy and anemia have been reported to be prognostic factors for CRPC patients in previous studies [16, 21, 22], and these factors were shown to be independent prognostic factors for CRPC patients treated with docetaxel in the present study.